Navigation Links
Yellowfin tuna biz concept a winner
Date:5/28/2009

VIRGINIA KEY, Fla. -- For the second year in a row, judges at the annual University of Miami (UM) School of Business Entrepreneurship Competition awarded prizes to a sustainable fisheries project developed by students from the UM Rosenstiel School of Marine and Atmospheric Science. At this year's 7th annual competition, John Stieglitz, a Marine Affairs and Policy graduate student, won runner-up and $3,000 in the competition's High-Potential Venture category. His venture, Blue Ocean Aquaculture, focuses on the production and shipment of sustainably cultured juvenile yellowfin tuna for the billion-dollar global offshore aquaculture industry and the capture-based tuna aquaculture industry.

Originally from Miami, Stieglitz received his undergraduate degree in Environmental Science from the University of Denver. Following years of charter fishing experience and Florida Keys/Everglades fish population research, he entered the University of Miami's Aquaculture Program in 2007. Stieglitz was awarded the Rosenstiel School's 2008 Iversen Award for Aquaculture.

Last year, classmates Aaron Welch and Ron Hoenig, both graduate students in the Rosenstiel School's Aquaculture Program, won first place in the High-Potential Venture category for their sustainable aquaculture concept designed to produce and sell valuable "goggle eye" bait retailers throughout the Sunshine State.

"We are very proud of the success Rosenstiel graduate students have had in this competition. It underscores the importance of sustainable aquaculture development and the technology we are capable of creating and delivering," said Dr. Daniel Benetti, professor and director of the UM Aquaculture Program. "Further proof of our recent success is that NOAA and the National Marine Fisheries Service have just funded our team to begin to look at growout technologies for two new species, blackfin tuna and goggle-eye." Stieglitz, Hoenig and Welch will be assuming leading roles in these
'/>"/>

Contact: Barbra Gonzalez
barbgo@rsmas.miami.edu
305-421-4704
University of Miami Rosenstiel School of Marine & Atmospheric Science
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Heat stress influences low conception of dairy herds
2. Misconceptions about Alzheimers varies among races, survey suggests
3. New Delft material concept for aircraft wings could save billions
4. Resilience concepts poised to aid management of coastal marine ecosystems
5. Moms obesity during conception phase may set the stage for offsprings obesity risk
6. Aquaculture concept leaves judges goggle eyed
7. Children born after donor insemination should be told as soon as possible about their conception
8. New roadside beautification concept studied
9. PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet
10. M&Ms as diet food? 100-calorie pack misconceptions
11. Complete Genomics releases proof-of-concept data for its sequencing technology for the first time
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Yellowfin tuna biz concept a winner
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
(Date:11/21/2014)... 20, 2014 Strict laws against distracted driving ... the North American and European automotive sector towards gesture ... recognition systems that are intuitive and able to retrieve ... industry. New analysis from Frost & ... in Europe and ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... the speed that ice travels in more than 200 outlet ... the 21st century could be significantly less than the upper ... a paper funded by the National Science Foundation (NSF) and ... While the study indicates that a melting Greenland,s contributions to ...
... Boston, MA A new study by Harvard School of ... high-density lipoprotein (HDL) cholesterol, the so-called "good" cholesterol, may not ... be harmful. , This is the first study to ... resides on the surface of HDL cholesterol may increase the ...
... Scientists at Cold Spring Harbor Laboratory (CSHL) and Memorial ... that commonly occurring large chromosomal deletions that are ... functionally linked genes whose loss, they posit, confers a ... closely at one large deletion -- a so-called copy-number ...
Cached Biology News:Analysis of speed of Greenland glaciers gives new insight for rising sea level 2Analysis of speed of Greenland glaciers gives new insight for rising sea level 3Some HDL, or 'good' cholesterol, may not protect against heart disease 2Clusters of cooperating tumor-suppressor genes are found in large regions deleted in common cancers 2Clusters of cooperating tumor-suppressor genes are found in large regions deleted in common cancers 3
(Date:12/24/2014)... Dec. 23, 2014 Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that investors including Oracle ... Fund LLC and several Vermillion directors have agreed ... of Vermillion,s common stock and warrants to purchase ... private placement.  Under the terms ...
(Date:12/24/2014)... Sigma-Aldrich Corporation (NASDAQ: SIAL ... the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in ... 2014, thereby completing the U.S. HSR Act antitrust ... the Company by Merck KGaA, Darmstadt, Germany.  ... to closing the transaction, which remains subject to ...
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... PharmAthene, Inc. (NYSE Amex: PIP ), a ... threats, today reported financial and operational results for the ... of 2009, PharmAthene recognized revenues of $5.5 million compared ... Revenues for the most recent quarter consisted primarily ...
... (OTC Bulletin Board: DORB) (DOR or the Company), a ... the first quarter of 2009. DOR,s revenues for the ... to $0.7 million for the first quarter of 2008. ... research and development amounts drawn down from DOR,s NIH ...
... Study and Orphan Drug DesignationROCKVILLE, Md., May 15 ... pharmaceutical company developing therapeutics for the treatment of cancer ... candidates at the American Society of Clinical Oncology (ASCO) ... 2, 2009 in Orlando, Florida. Presentations include both ...
Cached Biology Technology:PharmAthene Reports First Quarter 2009 Financial and Operational Results 2PharmAthene Reports First Quarter 2009 Financial and Operational Results 3PharmAthene Reports First Quarter 2009 Financial and Operational Results 4PharmAthene Reports First Quarter 2009 Financial and Operational Results 5PharmAthene Reports First Quarter 2009 Financial and Operational Results 6PharmAthene Reports First Quarter 2009 Financial and Operational Results 7DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 2DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 3DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 4DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments 5EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 2EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 3EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 4EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting 5
One-step, microplate or cuvet, colorimetric, linear detection range 8 mg/dL to 300 mg/dL. Procedure: 5 min....
Homo sapiens jumping translocation breakpoint...
One-step, microplate or cuvet, colorimetric 530nm, detection limit 0.16mg/dL in serum or plasma. Procedure: 10 min....
MOUSE ANTI HUMAN NPM...
Biology Products: